Critical Outcome Technologies
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Collip Cir Ste 230B, London, Ontario...Phone Number
(519) 858-5157Website
www.criticaloutcome.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Critical Outcome Technologies
Critical Outcome Technologies Inc. is a biopharmaceutical company focused on developing innovative treatments for various types of human cancers, with its lead project being COTI-2, a novel small molecule activator of misfolded mutant p53 proteins. The company utilizes its advanced drug discovery platform, Chemsas, to identify compounds with a higher probability of clinical and commercial success. Targeting serious diseases where current therapies are lacking, COTI has a robust pipeline of compounds and R&D collaborations. Their mission is to dramatically increase the odds of success in drug discovery and improve patient outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Critical Outcome Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Critical Outcome Technologies had a recent Job posting/layoffs
Check if Critical Outcome Technologies has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Critical Outcome Technologies has new funding data
Earning: See what the market has to say on Critical Outcome Technologies recently announced quarterly report
Check out if Critical Outcome Technologies is spiking on competitors!
Critical Outcome Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Critical Outcome Technologies launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Critical Outcome Technologies
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Critical Outcome Technologies
Compare insights from companies similar to Critical Outcome Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Critical Outcome Technolo...
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Critical Outcome Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Critical Outcome Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Critical Outcome Technologies.
Critical Outcome Technologies Tech Stack
A closer look at the technologies used by Critical Outcome Technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Critical Outcome Technologies
Sign Up For FreeTo access detailed company insights
Critical Outcome Technologies Inc. is a biopharmaceutical company focused on developing innovative treatments for various types of human cancers, with its lead project being COTI-2, a novel small molecule activator of misfolded mutant p53 proteins. The company utilizes its advanced drug discovery platform, Chemsas, to identify compounds with a high... Read More
